Publications by authors named "Satishkumar Singh"

Claim this Profile
T
The Novel Immunocompetent Eµ-SOX11CCND1 Mouse Model Phenotypically and Molecularly Resembles Human Mantle Cell Lymphoma.
Hedieh Jafari, Fiona Brown-Burke, Betsy Pray, Shelby Sloan, JoBeth Helmig-Mason, Satishkumar Singh

Clin Cancer Res· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-Derived Organoids and Xenografts Uncover Therapeutic Vulnerabilities in Colorectal Signet Ring Cell Carcinomas.
Nazia Chaudhary, Alessandro La Ferlita, Bhagya Shree Choudhary, Eeshrita Jog, Mufaddal Kazi, Satishkumar Singh

Clin Cancer Res· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting the DNA damage response through TBL1X in mantle cell lymphoma.
Betsy Pray, Ethan Baiocchi, Sydney Leon, Brian Barta, Shirsha Koirala, Satishkumar Singh

Blood Adv· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PRMT5 inhibition drives therapeutic vulnerability to combination treatment with BCL-2 inhibition in mantle cell lymphoma.
Fiona Brown-Burke, Inah Hwang, Shelby Sloan, Claire Hinterschied, JoBeth Helmig-Mason, Satishkumar Singh

Blood Adv· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploiting the fibroblast growth factor receptor-1 vulnerability to therapeutically restrict the MYC-EZH2-CDKN1C axis-driven proliferation in Mantle cell lymphoma.
Anuvrat Sircar, Satishkumar Singh, Zijun Y Xu-Monette, Krysta Mila Coyle, Laura K Hilton

Leukemia· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidermal growth factor-like 7 is a novel therapeutic target in mantle cell lymphoma.
Chinmayee Goda, Sofia Kolovich, Alexander Rudich, Malith Karunasiri, Rohan Kulkarni, Satishkumar Singh

Exp Hematol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retraction Note: AKT3-mediated IWS1 phosphorylation promotes the proliferation of EGFR-mutant lung adenocarcinomas through cell cycle-regulated U2AF2 RNA splicing.
Georgios I Laliotis, Evangelia Chavdoula, Maria D Paraskevopoulou, Abdul Kaba, Alessandro La Ferlita, Satishkumar Singh

Nat Commun· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of Bromodomain and Extra Terminal (BET) Domain Activity Modulates the IL-23R/IL-17 Axis and Suppresses Acute Graft--Host Disease.
Katiri J Snyder, Hannah K Choe, Yandi Gao, Natalie E Sell, Kara M Braunreiter, Satishkumar Singh

Front Oncol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Downregulation of ARID1B, a tumor suppressor in the WNT subgroup medulloblastoma, activates multiple oncogenic signaling pathways.
Akash Deogharkar, Satishkumar Vishram Singh, Harish Shrikrishna Bharambe, Raikamal Paul, Aliasgar Moiyadi

Hum Mol Genet· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AKT3-mediated IWS1 phosphorylation promotes the proliferation of EGFR-mutant lung adenocarcinomas through cell cycle-regulated U2AF2 RNA splicing.
Georgios I Laliotis, Evangelia Chavdoula, Maria D Paraskevopoulou, Abdul Kaba, Alessandro La Ferlita, Satishkumar Singh

Nat Commun· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integration of Metabolomics and Gene Expression Profiling Elucidates IL4I1 as Modulator of Ibrutinib Resistance in ABC-Diffuse Large B Cell Lymphoma.
Fouad Choueiry, Satishkumar Singh, Anuvrat Sircar, Georgios Laliotis, Xiaowei Sun

Cancers (Basel)· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transcriptional programming drives Ibrutinib-resistance evolution in mantle cell lymphoma.
Xiaohong Zhao, Michelle Y Wang, Huijuan Jiang, Tint Lwin, Paul M Park, Satishkumar Singh

Cell Rep· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting phosphatidylinositol 3 kinase-β and -δ for Bruton tyrosine kinase resistance in diffuse large B-cell lymphoma.
Neeraj Jain, Satishkumar Singh, Georgios Laliotis, Amber Hart, Elizabeth Muhowski, Ram Kumar Singh

Blood Adv· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact and Intricacies of Bone Marrow Microenvironment in B-cell Lymphomas: From Biology to Therapy.
Anuvrat Sircar, Sayan Mullick Chowdhury, Amber Hart, William Connor Bell, Satishkumar Singh

Int J Mol Sci· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Restoration of miR-30a expression inhibits growth, tumorigenicity of medulloblastoma cells accompanied by autophagy inhibition.
Satishkumar Vishram Singh, Aditi Nigam Dakhole, Akash Deogharkar, Sadaf Kazi, Rohan Kshirsagar

Biochem Biophys Res Commun· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis